 |
 |
 |
 |
 |
Orthopaedic Oncology
Patient Information
Welcome to the Orthopaedic Oncology Surgery Service. You
have been referred to us because you have a bone or soft tissue tumor which
is either benign or malignant. Not knowing whether your tumor is benign or
malignant is very stressful. We specialize in the diagnosis and treatment
of such tumors. We are all dedicated to diagnosing your tumor as quickly as
possible, and providing you with a treatment plan based on current research
and the latest limb-sparing surgical procedures. Our clinic involves a team
approach. Members of the team include the orthopaedic oncology surgeons, Francis
Hornicek, MD, PhD, and Kevin Raskin, MD, the radiation oncologists who deliver
radiation therapy, the hematology oncologists who manage chemotherapy treatments,
the pathologists who specialize in the diagnosis of bone and soft tissue tumors,
the radiologists who interpret all of the necessary x-rays and scans, and
a nurse practitioner who specializes in coordinating the care of patients
with tumors.
The Orthopaedic Oncology Program at the Massachusetts General Hospital was founded in 1972 by Dr. Henry Mankin, the then Chairperson of Orthopaedics. The program is now the largest oncology treatment group in New England and one of the largest in the world. Currently the program has two full-time physicians, Drs. Hornicek and Raskin who see approximately 200 patients per week including an average of 800 new patients annually with tumors of bone and soft tissues. With the help of two American fellows, two or three fellows from other parts of the world, two Orthopaedic residents and a nurse practitioner, the group performs approximately 700 operations per year at the Massachusetts General and maintains an active educational and research program.
Clinical Care
The Program cares for patients with tumors in three sites: the main offices of the group and in association with Radiation and Medical Oncology (the Connective Tissue Oncology Center) on Gray 6 of the Massachusetts General Hospital (MGH); Children's Hospital orthopaedic clinics; and i The types of patient problems range widely but an estimation is offered by the statistics for 2000 which show the group treated a total of 1217 new patients whose ages ranged from 2 to over 85 and whose principal diagnoses included both benign and malignant bone tumors. Benign tumors included 17 giant cell, 4 osteoblastomas, 82 enchondromas, 23 unicameral bone cysts, 16 aneurysmal bone cysts and 16 osteoid osteomas. Malignant bone tumors included 43 osteosarcomas, 18 chondrosarcomaas, 17 Ewings and 79 patients had metastatic cacner. Benign soft tissue masses included 65 liposarcomas and 29 hemangiomas. Malignant soft tissue sarcomas included 33 malignant fibrous histiocytomas, 22 liposarcomas, 13 synovial sarcomas, 1 leiomyosarcomas and 2 clear cell sarcomas. Over 700 operative procedures were performed which included 45 massive allograft replacements for the management of defects created by resection of the tumors in over 100 patients. Over 14,000 patients have been treated by our orthopaedic oncologists.
 |
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
|
|